Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Neurochemistry|August 4, 2004
AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal-regulated kinase to upregulate BDNF gene expressionXuan Wu, Daming Zhu, Xueying Jiang, et al.
Oncotargets and Therapy|December 20, 2012
Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinibFei Xu, Jingxun Wu, Cong Xue, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 13, 2017
Droplet digital PCR improved the EGFR mutation diagnosis with pleural fluid samples in non-small-cell lung cancer patientsXiaoyan Li, Yi Liu, Weiwei Shi, et al.
Anticancer Research|January 25, 2008
COX1 and COX2 polymorphisms and gastric cancer risk in a Polish populationLifang Hou, Paolo Grillo, Zhong-Zheng Zhu, et al.
Oncology|August 28, 2010
Association of genetic polymorphisms in STAT1 gene with increased risk of hepatocellular carcinomaZhong-Zheng Zhu, Jian-Zhong Di, Wen-Ye Gu, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 17, 2012
Sex-related differences in DNA copy number alterations in hepatitis B virus-associated hepatocellular carcinomaZhong-Zheng Zhu, Dong Wang, Wen-Ming Cong, et al.
BMC Cancer|February 28, 2014
Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinomaLiyan Jiang, Wei Zhu, Katie Streicher, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2017
Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs)Jia Zhong, Lei Li, Zhijie Wang, et al.
BMC Medicine|June 29, 2026
Engineered iMSCs delivering wild-type IL-2 achieve dose-sparing tumor control via CD25-dependent CD8+ T-cell activationShuqing Tang, Mengting Han, Peiyun Wang, et al.
American Journal of Human Genetics|April 28, 2006
Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorderXian-Zhang Hu, Robert H Lipsky, Guanshan Zhu, et al.
Pageof 5